戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  =.036 and P =.01, respectively) but not MDS refractory anemia with excess blasts.
2 th multilineage dysplasia (RCMD)-RS, 11 with refractory anemia with excess blasts-1 (RAEB1)-RS, and 5
3 tish classification: refractory anemia (20), refractory anemia with excess blasts (35), refractory an
4        Responders included two patients with refractory anemia with excess blasts and one patient wit
5 diagnosis, the FAB distinctions between MDS (refractory anemia with excess blasts and refractory anem
6 ts (RCMD-RS) and UPD4q24, and five patients (refractory anemia with excess blasts-II, n = 1; 5q- synd
7 lasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation (
8 ewly diagnosed acute myeloid leukemia (AML), refractory anemia with excess blasts in transformation (
9 ory anemia with ringed sideroblasts (9), and refractory anemia with excess blasts in transformation (
10 ewly diagnosed acute myeloid leukemia (AML), refractory anemia with excess blasts in transformation (
11   In current medical practice, patients with refractory anemia with excess blasts in transformation (
12 rthermore, we demonstrate that patients with refractory anemia with excess blasts in transformation (
13                       While in advanced MDS (refractory anemia with excess blasts in transformation [
14 DS (refractory anemia with excess blasts and refractory anemia with excess blasts in transformation)
15 emia with excess blasts and one patient with refractory anemia with excess blasts in transformation.
16                            Sixty percent had refractory anemia with excess blasts (n = 136) or with e
17 ractory anemia with ringed sideroblasts (5), refractory anemia with excess blasts (RAEB) (4), and RAE
18 ced complementary DNA from bone marrow of 47 refractory anemia with excess blasts (RAEB) patients, 29
19                    However, in the high-risk refractory anemia with excess blasts (RAEB) stages of MD
20               Following WHO recommendations, refractory anemia with excess blasts (RAEB)-2 diagnosis
21 vival durations were longer in patients with refractory anemia with excess blasts (RAEB).
22 excess blasts in transformation (RAEB-t), or refractory anemia with excess blasts (RAEB).
23 mic MDS patients (refractory anemia [RA] and refractory anemia with excess blasts [RAEB-1]) with ATG
24 or high-risk myelodysplastic syndrome (MDS) (refractory anemia with excess blasts [RAEB] or RAEB-t, 6
25 179 of 1505 loci after blast transformation (refractory anemia with excess blasts [RAEB]/AML).
26  refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。